Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/05/2012US20120083443 Control of ATP Release by Red Blood Cells and Therapeutic Applications Thereof
04/05/2012US20120083440 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
04/05/2012US20120083412 Composition and Method for Delivery of Substances in a Dry Mode Having a Surface Layer
04/05/2012US20120083004 Diagnostic Method for Celiac Sprue
04/05/2012US20120082742 Method and compositions for treating cutaneous verrucae
04/05/2012US20120082736 Small-molecule TNF modulator to reduce the side effects of chemotherapy and radiotherapy
04/05/2012US20120082732 Medicine for treatment of a carcinoma
04/05/2012US20120082730 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
04/05/2012US20120082729 Quick dissolve compositions and tablets based thereon
04/05/2012US20120082728 Multifunctional stealth nanoparticules for biomedical use
04/05/2012US20120082727 Use of magnesium stearate in dry powder formulations for inhalation
04/05/2012US20120082726 Surface-treated modafinil particles
04/05/2012US20120082722 Methods and compositions for oral delivery of fts
04/05/2012US20120082718 Morphine Formulations
04/05/2012US20120082717 Complex, multilayer using the same, and device coated with the multilayer
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082715 Stabilized products, processes and devices for preparing the same
04/05/2012US20120082714 Transdermal therapeutic system with crystallization-inhibiting protective film (release liner)
04/05/2012US20120082710 Methods and compositions for treating acne
04/05/2012US20120082706 Medical device for drug delivery
04/05/2012US20120082703 Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
04/05/2012US20120082702 Nicotinamide compounds useful as kinase modulators
04/05/2012US20120082684 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
04/05/2012US20120082677 Compositions for the treatment of hcv and hbv
04/05/2012US20120082659 Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
04/05/2012US20120082658 Methods for the Treatment of Allergic Diseases
04/05/2012US20120082653 Methods of lysosomal storage disease therapy
04/05/2012US20120082646 Antiviral Compounds And Uses Thereof
04/05/2012US20120082645 2'-c-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions, and uses thereof
04/05/2012US20120082640 Small molecule apoptosis promoters
04/05/2012US20120082636 Stabilized alpha helical peptides and uses thereof
04/05/2012US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
04/05/2012US20120082634 Treatment for dyslipidemia
04/05/2012US20120082632 Topical drug delivery system with dual carriers
04/05/2012US20120082627 Otic foam formulations
04/05/2012US20120082626 Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
04/05/2012US20120082625 Combination treatment for rosacea
04/05/2012US20120082623 SHH Regulation and Methods Thereof
04/05/2012US20120082621 Swallowtail motifs for imparting water solubility to porphyrinic compounds
04/05/2012US20120082616 Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers
04/05/2012DE102011000036A1 Rekombinante plasmidhaltige Mehrkopie-CpG-Motive und deren Transformanten zur Anwendung als DNA-Adjuvans in Vogel-Impfstoffen Recombinant plasmid-containing multi-copy CpG motifs and their transformants for use as DNA adjuvant in vaccines Bird
04/05/2012CA2860748A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012CA2860747A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012CA2849546A1 Dry processing of atazanavir
04/05/2012CA2815706A1 Use of nigericin to treat and prevent vaccinia virus infections
04/05/2012CA2813467A1 Minimizing intestinal dysfunction
04/05/2012CA2813466A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
04/05/2012CA2813256A1 Aryl-substituted imidazoles
04/05/2012CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
04/05/2012CA2813189A1 Novel methylcyclohexane derivatives and uses thereof
04/05/2012CA2813147A1 Preparation for improving solubility of poorly soluble drug
04/05/2012CA2813144A1 Chromene derivatives
04/05/2012CA2813096A1 Use of magnesium stearate in dry powder formulations for inhalation
04/05/2012CA2813093A1 Combination therapy for treating hcv infection
04/05/2012CA2813069A1 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
04/05/2012CA2812935A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012CA2812898A1 Cyclohexane derivative compound
04/05/2012CA2812859A1 Phenylquinazoline derivatives
04/05/2012CA2812846A1 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
04/05/2012CA2812790A1 Therapeutic use of a tlr agonist and combination therapy
04/05/2012CA2812787A1 Methods for the treatment of allergic diseases
04/05/2012CA2812753A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
04/05/2012CA2812751A1 Composition containing 2-acyl-lysophosphatidylserine and method for producing the same
04/05/2012CA2812750A1 Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases
04/05/2012CA2812744A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
04/05/2012CA2812686A1 Benzazole derivatives as histamine h4 receptor ligands
04/05/2012CA2812650A1 Use of mirnas for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities
04/05/2012CA2812649A1 Crystalline naloxol-peg conjugate
04/05/2012CA2812505A1 Pharmaceutical composition
04/05/2012CA2812438A1 Treatment of symptoms associated with menopause
04/05/2012CA2812414A1 Monovalent metal cation dry powders for inhalation
04/05/2012CA2812227A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012CA2811934A1 7-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonists
04/05/2012CA2811773A1 (aza)indolizine derivative and pharmaceutical use thereof
04/05/2012CA2811662A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012CA2811369A1 N-heteroaryl compounds
04/05/2012CA2811345A1 Compound composition for inhalation used for treating asthma
04/05/2012CA2811192A1 1,2,4-triazolone derivative
04/05/2012CA2811033A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/05/2012CA2810954A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
04/05/2012CA2810896A1 Crystalline oxalate salts of a diamide compound
04/05/2012CA2810825A1 Modulation of timp1 and timp2 expression
04/05/2012CA2810077A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
04/04/2012EP2436762A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
04/04/2012EP2436687A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
04/04/2012EP2436686A1 Pyrimidopyridine compound used as a CSBP/RK/p38 modulator
04/04/2012EP2436684A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
04/04/2012EP2436683A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
04/04/2012EP2436682A1 Co-crystals and pharmaceutical compositions comprising the same
04/04/2012EP2436680A2 Chroman derivatives, medicaments and use in therapy
04/04/2012EP2436676A1 Human adam-10 inhibitors
04/04/2012EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
04/04/2012EP2436673A1 Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-beta1-42 peptide
04/04/2012EP2436672A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
04/04/2012EP2436670A1 Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)-pyridone compounds and their salts
04/04/2012EP2436396A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/04/2012EP2436391A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
04/04/2012EP2436390A1 Topical Anesthetic Uses of Szeto-Schiller Peptides
04/04/2012EP2436386A1 Stable lyophilized preparation comprising anthracycline compound
04/04/2012EP2436385A1 Prophylactic or therapeutic agent for pulmonary fibrosis
1 ... 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 ... 7860